Savient Pharmaceuticals, Inc.
400 Crossing Boulevard
3rd Floor
Bridgewater,
NJ 08807
United States - Map
Phone: 732-418-9300
Website: http://www.savientpharma.com
Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company in the United States. It engages in developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients refractory to conventional therapy. The company also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. Savient Pharmaceuticals, Inc. sells its products through a network of specialty and wholesale distributors. The company was formerly known as Bio-Technology General Corp. and changed its name to Savient Pharmaceuticals, Inc. in June 2003. Savient Pharmaceuticals, Inc. was founded in 1980 and is headquartered in Bridgewater, New Jersey. Key Statistics
| |
| Savient Pharmaceuticals, Inc.’s ISS Governance QuickScore as of May 1, 2013 is 10. The pillar scores are Audit: 1; Board: 4; Shareholder Rights: 10; Compensation: 10. | | Brought to you by Institutional Shareholder Services (ISS) |
| | Pay | Exercised | Mr. Louis Ferrari ,
61
Chief Exec. Officer, Pres and Director | 1.08M | 0.00 | Mr. Richard P. Crowley ,
56
Chief Operating Officer and Exec. VP of Biopharmaceutical Operations | 988.00K | 0.00 | Dr. Kenneth M. Bahrt M.D.,
60
Chief Medical Officer and Sr. VP | 756.00K | 0.00 | Mr. John P. Hamill CPA,
49
Chief Financial Officer, Sr. VP and Treasurer | N/A | N/A | Mr. David G. Gionco ,
53
Group VP and Chief Accounting Officer | N/A | N/A |
|
| | Amounts are as of Dec 30, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year. | | Currency in USD. |
|
0.01(1.75%) May 17, 4:00PM EDT|After Hours
:
0.57